Comment on 'The role of aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis after total knee arthroplasty: a meta-analysis of randomized controlled trials'

Int J Surg. 2024 Jan 1;110(1):621-622. doi: 10.1097/JS9.0000000000000825.

Authors

Xiaofei Guo¹, Shuxian Zheng², Yong Zhi³

Affiliations

¹ Pediatric Orthopedics Department.
² Blood Transfusion Department, The Sixth Affiliated Hospital of Xinjiang Medical University.
³ College of Traditional Chinese Medicine, Xinjiang Medical University, Xinjiang, People's Republic of China.

No abstract available

MeSH terms

Anticoagulants / therapeutic use
Arthroplasty, Replacement, Knee* / adverse effects
Aspirin / therapeutic use
Heparin, Low-Molecular-Weight / therapeutic use
Humans
Randomized Controlled Trials as Topic
Venous Thromboembolism* / etiology
Venous Thromboembolism* / prevention & control

Substances

Heparin, Low-Molecular-Weight
Aspirin
Anticoagulants